SCHEMBL3866765

SCHEMBL3866765

Cc1ccc(Sc2cccc3c4c(n(C)c23)CCN(C(=O)OC(C)(C)C)C4)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
DDB1 Q16531 1/20 0.42
CRBN Q96SW2 1/20 0.42
HDAC10 Q969S8 1/20 0.38
ESR2 Q92731 1/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
ADORA1 P30542 1/20 0.37
F12 P00748 2/20 0.37
PDK4 Q16654 1/20 0.37
MKNK1 Q9BUB5 1/20 0.37
MAPK1 P28482 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
NR1H2 P55055 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
LIPG Q9Y5X9 1/20 0.35
PRNP P04156 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
C5AR1 P21730 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3865365 0.86 PTGDR2 (0.41) HDAC1HDAC6HDAC10ALDH1A1POLB
SCHEMBL1841759 0.86 HDAC6 (0.48) HDAC1HDAC6DDB1CRBNHDAC10
SCHEMBL3857762 0.82 HDAC6 (0.44) HDAC1HDAC6HDAC10ALDH1A1POLB
SCHEMBL21154247 0.80 HDAC1 (0.49) HDAC1HDAC6DDB1CRBNHDAC10
SCHEMBL3859443 0.79 LMNA (0.44) HDAC1HDAC6DDB1CRBNESR2
SCHEMBL3859519 0.79 HDAC1 (0.43) HDAC1HDAC6HDAC10ALDH1A1POLB
SCHEMBL30506410 0.77 HDAC6 (0.60) HDAC1HDAC6DDB1CRBNHDAC10
SCHEMBL21114856 0.77 HDAC6 (0.60) HDAC1HDAC6DDB1CRBNHDAC10
SCHEMBL4791634 0.74 ESR2 (0.43) HDAC1HDAC6DDB1CRBNHDAC10
SCHEMBL4794081 0.74 GPR119 (0.45) ESR2ALDH1A1POLBPDK4GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592454-B2 Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2009-09-22 US disclosed
WO-2005105082-A1 SUBSTITUTED HEXAHYDRO-PYRIDOINDOLE DERIVATIVES AS SEROTONIN RECEPTOR AGONISTS AND ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-11-10 WO disclosed
US-20050239768-A1 Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists BRISTOL-MYERS SQUIBB COMPANY 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239768-A1 Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists HTR1A, HTR7, HTR1D HDAC1 1630/4885HDAC6 2570/4885DDB1 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.